Sign in

CIK 0001894562 · <br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. 8-K Event Regulation FD disclosure
  2. SCHEDULE 13D/A Stake Beneficial Ownership Report
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 8-K Event Executive or director change · Shareholder vote results
  16. 4 Open-market buy 10% owner bought 1,500,000 shares at $3.30 ($4,950,000)
  17. 4 Open-market buy Director bought 3,030,300 shares at $3.30 ($9,999,990)
  18. 4 Open-market buy 10% owner bought 3,030,300 shares at $3.30 ($9,999,990)
  19. 4 Open-market buy 10% owner bought 3,030,300 shares at $3.30 ($9,999,990)
  20. 8-K Event Material agreement

Page 3 of 16 · 302 filings